The relationship between systemic anticoagulation during cardiac surgery and heparin platelet factor 4 antibody formation.

被引：1
|
作者：
Francis, JL [1 ]
Drexler, A [1 ]
Walker, J [1 ]
Rathmann, K [1 ]
机构：
[1] Florida Hosp Med Ctr, Ctr Thrombosis & Hemostasis, Orlando, FL 32803 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.3951.3951
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3951
引用
收藏
页码：74B / 74B
页数：1
相关论文
共 50 条
  • [1] GENOME-WIDE ASSOCIATION STUDY OF PLATELET FACTOR 4/HEPARIN ANTIBODY FORMATION.
    Karnes, J. H.
    Denny, J. C.
    Bowton, E. A.
    Shaffer, C. M.
    Mosley, J. D.
    Van Driest, S.
    Weeke, P. E.
    Wells, Q. S.
    Roden, D. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S27 - S28
  • [2] The prevalence of heparin/platelet factor 4 antibody is high in patients undergoing cardiac surgery
    Everett, BM
    Foo, SY
    Criss, D
    Van Cott, EM
    Laposata, M
    Jang, IK
    Torchiana, D
    Walker, JF
    CIRCULATION, 2004, 110 (17) : 358 - 358
  • [3] Atherosclerosis is not a risk factor for anti-platelet factor 4/heparin antibody formation after cardiopulmonary bypass surgery
    Cuker, Adam
    Rauova, Lubica
    Bolgiano, Douglas
    Matthai, William H., Jr.
    Poncz, Mortimer
    Konkle, Barbara A.
    THROMBOSIS AND HAEMOSTASIS, 2014, 111 (06) : 1191 - 1193
  • [4] The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population
    Mullen, Mary P.
    Wessel, David L.
    Thomas, Kristen C.
    Gauvreau, Kimberlee
    Neufeld, Ellis J.
    McGowan, Francis X., Jr.
    DiNardo, James A.
    ANESTHESIA AND ANALGESIA, 2008, 107 (02): : 371 - 378
  • [5] The clinical significance of heparin/platelet factor 4 antibodies after cardiac surgery
    Filipescu, D. C.
    Calugareanu, A.
    Luchian, M.
    Ghenu, O.
    Marin, S.
    Dima, L.
    Uscatescu, V
    Ghomchi, H.
    Iliuta, L.
    Iliescu, V
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 878 - 878
  • [6] Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery
    Everett, Brendan M.
    Yeh, Robert
    Foo, Shi Yin
    Criss, David
    Van Cott, Elizabeth M.
    Laposata, Michael
    Avery, Edwin G.
    Hoffman, William D.
    Walker, Jennifer
    Torchiana, David
    Jang, Ik-Kyung
    ANNALS OF THORACIC SURGERY, 2007, 83 (02): : 592 - 597
  • [7] Mechanical prophylaxis is a heparin-independent risk for anti-platelet factor 4/heparin antibody formation after orthopedic surgery
    Bito, Seiji
    Miyata, Shigeki
    Migita, Kiyoshi
    Nakamura, Mashio
    Shinohara, Kazuhito
    Sato, Tomotaro
    Tonai, Takeharu
    Shimizu, Motoyuki
    Shibata, Yasuhiro
    Kishi, Kazuhiko
    Kubota, Chikara
    Nakahara, Shinnosuke
    Mori, Toshihito
    Ikeda, Kazuo
    Ota, Shusuke
    Minamizaki, Takeshi
    Yamada, Shigeru
    Shiota, Naofumi
    Kamei, Masataka
    Motokawa, Satoru
    BLOOD, 2016, 127 (08) : 1036 - 1043
  • [8] Positive heparin-platelet factor 4 antibody complex and cardiac surgical outcomes
    Kress, David C.
    Aronson, Solomon
    McDonald, Monica L.
    Malik, Mohammad I.
    Divgi, Ajit B.
    Tector, Alfred J.
    Downey, Francis X., III
    Anderson, Alfred J.
    Stone, Mia
    Clancy, Cassandra
    ANNALS OF THORACIC SURGERY, 2007, 83 (05): : 1737 - 1743
  • [9] Heparin Platelet Factor 4 Antibody Positivity in Pseudothrombocytopenia
    Balcik, Ozlem Sahin
    Akdeniz, Derya
    Cipil, Handan
    Uysal, Sema
    Isik, Ayse
    Kosar, Ali
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2012, 18 (01) : 92 - 95
  • [10] REVERSAL OF HEPARIN ANTICOAGULATION BY RECOMBINANT PLATELET FACTOR-4 IN HUMANS
    DEHMER, GJ
    FISHER, M
    TATE, DA
    TEO, S
    BONNEM, EM
    CIRCULATION, 1995, 91 (08) : 2188 - 2194
12345